The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder
- Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") stock (stock abbreviation: Baicheng Pharmaceutical, stock code: 301096) will resume trading on June 1, 2026 (Monday) at market opening.
- The termination of the planning for the change of control will not adversely affect the Company's production and operations, nor will it impact the Company's future development strategy. Investors are advised to invest rationally and pay attention to investment risks.